Genmab Shares Jump on Rina-S Ovarian Cancer Data
Genmab Shares Jump as Rina-S Shows Durable Ovarian Cancer Responses in Phase 2 Trial Genmab shares jumped more than 4% on Monday after the...
Category: Cancer Drugs
Summit Stock Surges on AstraZeneca’s $2B Deal
Summit Therapeutics Shares Surge After AstraZeneca’s $2 Billion Investment Summit Therapeutics shares jumped more than 15% in after-hours ...